# Glutamate for Metabolic Intervention in Coronary Surgery II

Study · id `cardio:ct-nct02592824` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02592824](<https://clinicaltrials.gov/study/NCT02592824>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02592824

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.

## Technical summary

Registry record NCT02592824. Randomized; quadruple masking; primary purpose prevention. Start 2015-11-15 (actual); primary completion 2020-10-30 (actual). Results posted on 2023-12-04.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 321 participants (enrolled count; ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Started: 2015-11-15 (actual) (ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Primary completion: 2020-10-30 (actual) (ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Completion: 2020-10-30 (actual) (ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Results first posted: 2023-12-04 (ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT02592824, source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02592824-2023-12-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Glutamate for Metabolic Intervention in Coronary Surgery II
- Acronym: GLUTAMICSII
- Condition: Coronary Artery Bypass Surgery
- Condition: Postoperative Complications
- Condition: Heart Failure
- Intervention (Drug): glutamate infusion
- Intervention (Drug): saline infusion
- Lead sponsor: University Hospital, Linkoeping
- Lead sponsor class: OTHER
- Collaborator: Region Örebro County
- Collaborator class: OTHER
- Collaborator: University Hospital, Umeå
- Collaborator class: OTHER
- Collaborator: Sahlgrenska University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University Hospital, Linkoeping (`cardio:org-university-hospital-linkoeping`)
- Registry lists this organization as a collaborator: Region Örebro County (`cardio:org-region-orebro-county`)
- Registry lists this organization as a collaborator: University Hospital, Umeå (`cardio:org-university-hospital-umea`)
- Registry lists this organization as a collaborator: Sahlgrenska University Hospital (`cardio:org-sahlgrenska-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial (`cardio:pubmed-35533197`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ceadeba6c8aef3ccfb8abd85a24a0de47844281e04527e14040ba92ccf76ab70
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
